Nisa Investment Advisors’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$53K Sell
2,216
-1,100
-33% -$26.3K ﹤0.01% 1573
2025
Q1
$82.4K Buy
3,316
+12
+0.4% +$298 ﹤0.01% 1449
2024
Q4
$62.2K Buy
3,304
+2,749
+495% +$51.8K ﹤0.01% 1615
2024
Q3
$8.35K Sell
555
-26
-4% -$391 ﹤0.01% 2127
2024
Q2
$16.6K Buy
581
+46
+9% +$1.32K ﹤0.01% 2010
2024
Q1
$15.6K Buy
535
+46
+9% +$1.34K ﹤0.01% 1954
2023
Q4
$16.5K Sell
489
-1,512
-76% -$51K ﹤0.01% 1929
2023
Q3
$61.4K Buy
2,001
+1,514
+311% +$46.5K ﹤0.01% 1664
2023
Q2
$19.5K Sell
487
-449
-48% -$18K ﹤0.01% 2113
2023
Q1
$38K Sell
936
-655
-41% -$26.6K ﹤0.01% 1800
2022
Q4
$61K Buy
1,591
+9
+0.6% +$345 ﹤0.01% 1714
2022
Q3
$82K Sell
1,582
-129
-8% -$6.69K ﹤0.01% 1571
2022
Q2
$100K Buy
1,711
+124
+8% +$7.25K ﹤0.01% 1505
2022
Q1
$121K Sell
1,587
-138
-8% -$10.5K ﹤0.01% 1555
2021
Q4
$108K Sell
1,725
-3,846
-69% -$241K ﹤0.01% 1490
2021
Q3
$312 Buy
5,571
+1,033
+23% +$58 ﹤0.01% 1263
2021
Q2
$275 Sell
4,538
-1,400
-24% -$85 ﹤0.01% 1310
2021
Q1
$416 Hold
5,938
﹤0.01% 1219
2020
Q4
$355K Buy
5,938
+3,763
+173% +$225K ﹤0.01% 1270
2020
Q3
$131K Sell
2,175
-21,146
-91% -$1.27M ﹤0.01% 1454
2020
Q2
$1.22M Buy
23,321
+15,531
+199% +$815K 0.01% 723
2020
Q1
$261K Buy
7,790
+300
+4% +$10.1K ﹤0.01% 1120
2019
Q4
$339K Buy
7,490
+300
+4% +$13.6K ﹤0.01% 1208
2019
Q3
$274K Sell
7,190
-558
-7% -$21.3K ﹤0.01% 1250
2019
Q2
$337K Hold
7,748
﹤0.01% 1192
2019
Q1
$295K Buy
7,748
+7,398
+2,114% +$282K ﹤0.01% 1205
2018
Q4
$15K Sell
350
-55
-14% -$2.36K ﹤0.01% 1555
2018
Q3
$20K Hold
405
﹤0.01% 1556
2018
Q2
$13K Buy
405
+230
+131% +$7.38K ﹤0.01% 1656
2018
Q1
$5K Buy
+175
New +$5K ﹤0.01% 1796
2016
Q4
Sell
-400
Closed -$14K 1887
2016
Q3
$14K Hold
400
﹤0.01% 1744
2016
Q2
$13K Hold
400
﹤0.01% 1746
2016
Q1
$21K Buy
+400
New +$21K ﹤0.01% 1594